Amal A M Ahmed Selected Research

lonazolac (Argun)

1/2022

Possible Protective Potency of Argun Nut (Medemia argun - An Ancient Egyptian Palm) against Hepatocellular Carcinoma in Rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Amal A M Ahmed Research Topics

Disease

2	Neoplasms (Cancer) 01/2022 - 08/2020
2	Inflammation (Inflammations) 07/2020 - 10/2017
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Diabetic Cardiomyopathies 09/2021
1	Alcoholic Fatty Liver 07/2020
1	Hypertriglyceridemia 07/2020
1	Hyperglycemia 07/2020
1	Hyperinsulinism (Hyperinsulinemia) 07/2020
1	Insulin Resistance 07/2020
1	Body Weight (Weight, Body) 07/2020
1	Non-alcoholic Fatty Liver Disease 07/2020
1	Fatty Liver 07/2020
1	Hyperalgesia 01/2019
1	Cardiotoxicity 10/2017
1	Endotoxemia 05/2017
1	Seizures (Absence Seizure) 04/2017
1	Stomatitis 02/2017
1	Ischemia 03/2009

Drug/Important Bio-Agent (IBA)

2	EnzymesIBA 01/2022 - 07/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2020 - 03/2009
1	Superoxide DismutaseIBA 01/2022
1	Malondialdehyde (Propanedial)IBA 01/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022
1	lonazolac (Argun)IBA 01/2022
1	AntioxidantsIBA 01/2022
1	Glutathione (Reduced Glutathione)IBA 01/2022
1	Erythropoietin FDA Link 09/2021
1	dapagliflozinIBA 09/2021
1	Streptozocin (Streptozotocin)FDA Link 09/2021
1	jaceidinIBA 08/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2020
1	FlavonoidsIBA 08/2020
1	Blood Glucose (Blood Sugar)IBA 07/2020
1	Exenatide (Byetta)FDA Link 07/2020
1	Toll-Like Receptor 4IBA 07/2020
1	Lipid PeroxidesIBA 07/2020
1	Metformin (Glucophage)FDA LinkGeneric 07/2020
1	Donepezil (Aricept)FDA LinkGeneric 01/2019
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2017
1	allicinIBA 10/2017
1	Antineoplastic Agents (Antineoplastics)IBA 10/2017
1	LipopolysaccharidesIBA 05/2017
1	ColforsinIBA 05/2017
1	Thromboplastin (Tissue Factor)IBA 05/2017
1	Celecoxib (Celebrex)FDA Link 05/2017
1	evening primrose oilIBA 05/2017
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2017
1	Thioctic Acid (Lipoic Acid)IBA 02/2017
1	Methotrexate (Mexate)FDA LinkGeneric 02/2017
1	KATP ChannelsIBA 03/2009
1	PotassiumIBA 03/2009
1	Adenosine Triphosphate (ATP)IBA 03/2009
1	Peroxidase (Myeloperoxidase)IBA 03/2009
1	Superoxides (Superoxide)IBA 03/2009